State v. J.D.B. (2026 WI 5): Appellate Review of Sell Factors—De Novo for Governmental Interest; Clear Error for Factors 2–4; No Mandatory “Green” Checklist

I. Introduction

Parties and posture. The State of Wisconsin petitioned for review after the court of appeals reversed a Milwaukee County Circuit Court order authorizing the involuntary administration of antipsychotic medication to J.D.B. (“Jared,” a pseudonym) to restore competency to stand trial for battery to a law enforcement officer (Class H felony). The Supreme Court of Wisconsin reversed the court of appeals and reinstated the involuntary medication order.

Background. After Jared’s arrest (following threats and an alleged strike to an officer), the circuit court ordered a competency evaluation. DHS diagnosed schizophrenia and found him incompetent and unable to assist counsel. Jared’s behavior deteriorated after he refused antipsychotic medication in a mental health institution, prompting DHS psychiatrist Dr. Illichmann to seek an involuntary medication order.

Key issues. The case presented two statewide questions that recur yet often evade review due to short order duration and mootness:

  • Constitutional: Whether the circuit court properly applied the four factors from Sell v. United States to authorize forced medication to restore trial competency.
  • Appellate framework: What is the correct standard of review for each Sell factor on appeal.
  • Statutory: Whether the State met WIS. STAT. § 971.14(3)(dm) and (4)(b) (competence to refuse medication—understanding/applying advantages, disadvantages, and alternatives).

Mootness. Although the order expired pending appeal, the court decided the merits, relying on its established practice in this area (citing State v. Fitzgerald and Winnebago Cnty. v. C.S.).

II. Summary of the Opinion

The Wisconsin Supreme Court held:

  1. Standard of review:
    • Sell factor 1 (“important governmental interests are at stake”) is reviewed de novo, with deference only to underlying historical facts.
    • Sell factors 2–4 (efficacy/fair-trial side effects; necessity/least intrusive alternatives; medical appropriateness) are factual findings reviewed for clear error.
  2. No mandatory evidentiary checklist: To the extent State v. Green is read to require a fixed checklist of evidentiary items for factors 2–4, it is overruled. Sell requires an individualized plan and findings, but allows flexibility in proof.
  3. Merits: Applying the above standards, the court concluded (i) the State had an important interest in prosecuting a serious felony, and (ii) the circuit court’s findings on factors 2–4 were not clearly erroneous.
  4. Statutory compliance: The circuit court’s findings under WIS. STAT. § 971.14(3)(dm) were supported by evidence and not clearly erroneous; Outagamie County v. Melanie L did not impose additional mandatory evidentiary requirements beyond the statute.

Dissent (Crawford, J.). The dissent would have held that special circumstances (likely civil commitment and extended pretrial confinement) sufficiently diminished the State’s prosecutorial interest under factor 1, making forced medication unconstitutional in this case.

III. Analysis

A. Precedents Cited

1. Core federal due process cases governing forced antipsychotic medication

  • Washington v. Harper: Recognized a “significant liberty interest in avoiding the unwanted administration of antipsychotic drugs.” The majority frames Sell as operating within Harper’s due-process liberty-interest architecture, requiring an “essential” or “overriding” governmental interest to justify forced medication.
  • Sell v. United States: Supplies the controlling four-factor constitutional test when the purpose of medication is trial competency restoration (not dangerousness management or institutional order). The Wisconsin Supreme Court treats Sell as imposing mandatory judicial findings beyond Wisconsin’s current statutory text.

2. Wisconsin’s prior incorporation of Sell

  • State v. Fitzgerald: Held WIS. STAT. § 971.14’s involuntary medication provisions are unconstitutional to the extent they authorize forced medication to restore competency without Sell findings. J.D.B. builds on Fitzgerald by answering a question left open: how appellate courts review each Sell factor.

3. The contested Wisconsin intermediate precedent on evidentiary specificity

  • State v. Green: In Green, the court of appeals rejected a generic, non-individualized plan. It also listed numerous data points (medication, max dosages, duration, age, weight, history, etc.). The majority in J.D.B. accepts Green’s core point—individualized plans are required—but rejects any reading that turns the list into a constitutionally mandated checklist, concluding Sell does not demand that level of rigid specificity. The court expressly states that, to the extent Green created a mandatory checklist, it is “overruled.”

4. Authorities supporting the standards-of-review framework

  • Utah v. Thurman and Ronald R. Hofer, Standards of Review-Looking Beyond the Labels: Used to explain institutional roles: trial courts as superior factfinders; appellate courts as norm-setters. These sources supply the jurisprudential justification for de novo review of the “important governmental interest” determination (a predominantly legal/normative judgment) versus clear-error review for medical/evidentiary assessments (predominantly factual).
  • State v. Owens: Cited for the proposition that trial judges’ access to demeanor and live testimony justifies deference on fact findings.
  • State v. Burch, Serv. Emps. Int'l Union Healthcare v. WERC, and C.J.S.: Reinforce Wisconsin’s general division: clear-error review for facts; de novo for law.
  • State v. Byrge and State v. Pepin: Used for mixed-question methodology and how Wisconsin allocates law/fact in appellate review.
  • State v. Wiskerchen: Provides the formulation of clear-error review applied to factors 2–4 (“reasonable person” could make the finding; appellate court searches for supporting evidence).

5. Federal appellate consensus on reviewing Sell factors

The majority noted near-unanimity among federal circuits: factor 1 is reviewed as a legal question, while factors 2–4 are reviewed for clear error. It cited, among others, United States v. Gomes, United States v. Grape, United States v. Evans, United States v. Palmer, United States v. Green (federal), United States v. Fieste, United States v. Fazio, United States v. Hernandez-Vasquez, United States v. Bradley, United States v. Diaz, and United States v. Dillon. The court also relied on United States v. Tucker for the institutional-competence rationale supporting deference on medical factfinding.

6. Other cited authorities shaping application of factor 1 and statutory issues

  • State v. Steffes: Invoked to reject issuing advisory opinions (here, declining to adopt a generalized “seriousness” framework beyond what was necessary to decide the case).
  • United States v. Mikulich: Used to reject the argument that a potential NGI defense diminishes the interest in prosecution; a defense that can be asserted only within prosecution cannot logically justify skipping prosecution.
  • Outagamie County v. Melanie L: Cited and limited: the majority held it did not add mandatory evidentiary elements beyond statutory language; it was discussed as overview and not on-point holdings for the disputed issue.

7. Dissent’s additional comparative authorities

Justice Crawford’s dissent cited United States v. Berry, United States v. Valenzuela-Puentes, United States v. Hernandez-Vasquez (also in majority), and State v. Gallion to emphasize that likely sentence and time served can materially weaken the prosecutorial interest under factor 1.

B. Legal Reasoning

1. The opinion’s principal doctrinal move: allocating appellate responsibility

The court’s most consequential holding is structural: it delineates which parts of the Sell inquiry are primarily normative/legal (factor 1) versus primarily medical/evidentiary (factors 2–4). This allocation is not merely procedural; it determines how often involuntary medication orders will survive appeal.

  • Factor 1 (de novo): The “importance” of prosecution is treated as a statewide legal judgment about when government interest becomes weighty enough to override bodily autonomy. Underlying historical facts (e.g., time confined, pending civil commitment status) remain subject to deference, but their legal significance is assessed independently.
  • Factors 2–4 (clear error): The court characterizes efficacy, side effects, necessity/alternatives, and medical appropriateness as expert-driven factual determinations. This choice implicitly trusts circuit courts to sift competing expert views and treatment records and to translate them into individualized findings.

2. Factor 1 applied: seriousness plus “special circumstances” as mitigation, not a rigid subtest

The court reads Sell as establishing a “single unified question” for factor 1: whether the State’s interest remains important in light of individualized mitigating circumstances. “Special circumstances” are not a checklist; they are contextual considerations that can reduce (but usually not eliminate) the prosecutorial interest.

Applying that approach, the majority accepted that the charged felony is serious and rejected several asserted mitigators:

  • Potential NGI: rejected as “logically backwards” (relying on United States v. Mikulich).
  • Alleged bail/pretrial detention errors: deemed not tied to the State’s prosecutorial interest.
  • Delayed treatment/system failures: not shown to diminish the “far broader” criminal justice interest.
  • Mental health crisis/youth/no record/civil commitment possibility: civil commitment was speculative at the time and, per Sell, not a substitute for trial.
  • Time served: recognized as mitigating, but insufficient to erase the State’s interest given broader goals (timely prosecution, community interests).

3. Factors 2–4 applied: individualized plan required, but flexible proof suffices

The court’s treatment of State v. Green is central to its approach on factors 2–4. It draws a line between: (a) an impermissible “generic” plan untethered to the defendant; and (b) an individualized plan that may still use medical judgment ranges (e.g., titration within FDA-approved dosage ranges).

Here, the majority emphasized record features supporting deference:

  • Dr. Illichmann reviewed medical records (including prior competency material) and met Jared multiple times.
  • He testified to intended medications, purpose (treating psychosis), and side effects; he described dose titration and starting doses.
  • The circuit court made express findings tracking Sell’s language (substantially likely to restore competency; substantially unlikely to impair fairness; necessity; medical appropriateness).

Under clear-error review, these features were enough even though the treatment plan arguably misstated aspects of Jared’s physical comorbidities—because the trial court could reasonably credit the physician’s testimony that he reviewed relevant records and discussed risks.

4. Statutory findings under WIS. STAT. § 971.14(3)(dm)

After resolving constitutional requirements, the court confirmed that Wisconsin’s statutory prerequisites were also satisfied. The statute requires proof that: (1) advantages/disadvantages/alternatives were explained; and (2) due to mental illness, the defendant is incapable of expressing understanding or substantially incapable of applying understanding to make an informed choice.

The court held the circuit court’s findings were supported by Dr. Illichmann’s testimony that he explained risks and benefits in two meetings and that Jared’s repeated response (“doesn’t need” medication) reflected inability to apply information to his situation. The majority rejected the argument that Outagamie County v. Melanie L imposed additional evidentiary burdens.

C. Impact

1. A new Wisconsin appellate template for forced-medication orders

Immediate effect. J.D.B. supplies the missing appellate rubric after State v. Fitzgerald: de novo review for factor 1; clear-error review for factors 2–4. This will standardize appellate outcomes and briefing strategies in competency-restoration medication cases.

2. Reduced reversals based on evidentiary “completeness” arguments

By overruling any mandatory-checklist reading of State v. Green, the court lowers the risk that involuntary medication orders will be reversed because a plan fails to recite every listed data point (e.g., weight, maximum dosages, full medical record detail). The constitutional floor becomes: an individualized plan and findings supported by evidence—without rigid formalism.

3. Strategic re-centering of litigation on factor 1

Because factor 1 is reviewed de novo, it becomes the most appellate-sensitive part of the Sell inquiry. Defendants may focus on building a record of “special circumstances” (time served, likely civil commitment, sentencing realities), while the State will emphasize seriousness and broader prosecution interests (timeliness, accountability, deterrence, community protection).

4. Institutional consequence: greater trial-court authority on medical judgments

The clear-error standard for factors 2–4 strongly insulates circuit-court medical factfinding from appellate reweighing. In practice, this means the quality of the expert record at the circuit court level—especially individualized explanation of expected benefits, side effects, and alternatives—will largely determine outcomes.

5. Doctrinal tension preserved: how “mitigating” must mitigating be?

The dissent highlights an unresolved pressure point: how to measure the State’s interest when likely sentence is short and pretrial confinement is long. The majority rejected a rule-like approach and required a clearer connection between proposed mitigators and the prosecutorial interest; the dissent would have found mitigation sufficient here. Future cases may turn on more developed records about civil commitment likelihood and sentencing expectations.

IV. Complex Concepts Simplified

Competency to stand trial
A defendant is competent if he can understand the proceedings and assist counsel. If not, criminal proceedings pause and treatment may be ordered to restore competency.
Involuntary medication order (competency restoration)
A court order permitting forced administration of psychotropic medication to restore competency so the defendant can be tried. Because this invades bodily autonomy, due process requires strict safeguards.
The four Sell factors
A constitutional test from Sell v. United States:
  1. Important governmental interest in prosecution (usually satisfied by a serious charge unless special circumstances strongly mitigate).
  2. Efficacy and fairness: medication is substantially likely to restore competency and substantially unlikely to cause side effects that impair trial fairness.
  3. Necessity: no less intrusive alternative would suffice (e.g., therapy alone, voluntary compliance).
  4. Medical appropriateness: the regimen is in the patient’s best medical interest.
Standard of review: “de novo” vs. “clear error”
  • De novo: the appellate court decides the issue independently.
  • Clear error: the appellate court defers to the trial court unless the finding lacks reasonable support in the record.
In J.D.B., factor 1 is de novo; factors 2–4 are clear error.
“Individualized treatment plan”
A medication plan tailored to the specific defendant’s condition and history, not a generic template. J.D.B. reaffirms individualization is required, but rejects a rigid checklist of required details.
Mootness
A case is “moot” if the order has expired and there is no effective relief. Courts may still decide moot issues that are important, recurring, and likely to evade review—common in short-duration competency and medication orders.

V. Conclusion

State v. J.D.B. establishes Wisconsin’s definitive appellate approach to Sell-based forced-medication orders: factor 1 is reviewed de novo, while factors 2–4 are factual findings reviewed for clear error. It further clarifies that Sell requires an individualized plan and individualized findings, but does not mandate a fixed evidentiary checklist—overruling State v. Green to the extent it is read otherwise. Finally, the court reaffirms that WIS. STAT. § 971.14(3)(dm) demands proof of explanation of risks/benefits/alternatives and the defendant’s inability to understand or apply them, while rejecting arguments that Outagamie County v. Melanie L adds extra proof requirements.

The decision will likely shift future litigation toward the de novo “important governmental interest” inquiry, while making circuit-court medical factfinding on efficacy, necessity, and medical appropriateness more resistant to appellate reversal—so long as the record supports individualized reasoning.